ID SU-DHL-7 AC CVCL_4380 SY SUDHL7; SUDHL-7; SuDHL 7; Stanford University-Diffuse Histiocytic Lymphoma-7; DHL-7; DHL7 DR cancercelllines; CVCL_4380 DR Cosmic; 850206 DR Cosmic; 1290018 DR Cosmic; 1517608 DR Cosmic; 1541912 DR Cosmic; 1945193 DR Cosmic; 2276341 DR Cosmic; 2361373 DR DSMZ; ACC-903 DR DSMZCellDive; ACC-903 DR GEO; GSM380148 DR GEO; GSM552466 DR GEO; GSM1035335 DR Progenetix; CVCL_4380 DR Wikidata; Q54970722 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=83902; RX PubMed=214220; RX PubMed=371794; RX PubMed=3881165; RX PubMed=8547074; RX PubMed=9787181; RX PubMed=19278952; RX PubMed=19358282; RX PubMed=20628145; RX PubMed=23292937; CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00557. CC Doubling time: ~50 hours (DSMZ=ACC-903). CC Omics: Genomics; Whole exome sequencing. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; miRNA profiling; Microarray. CC Omics: Variations; Array-based CGH. CC Omics: Variations; CNV analysis. CC Omics: Variations; SNP array analysis. CC Caution: Was reported in Cellosaurus and the ICLAC Register (from 2018 to early 2022) to be a SU-DHL-8 contaminated cell line but there seem to have been an issue with the sample tested. DSMZ has obtained original stock from Epstein A.L. and SU-DHL-7 is a genuine non-problematic cell line. CC Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. ST Source(s): DSMZ=ACC-903 ST Amelogenin: X ST CSF1PO: 10,12 ST D13S317: 12,13 ST D16S539: 9,12 ST D18S51: 14,15 ST D19S433: 12,14 ST D21S11: 32.2 ST D2S1338: 16,20 ST D3S1358: 16 ST D5S818: 11,13 ST D7S820: 10,11 ST D8S1179: 12,14 ST FGA: 20,25 ST Penta D: 13 ST Penta E: 12,15 ST TH01: 7,9.3 ST TPOX: 8 ST vWA: 16,17 DI NCIt; C8851; Diffuse large B-cell lymphoma DI ORDO; Orphanet_544; Diffuse large B-cell lymphoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 47Y CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 32 // RX PubMed=371794; RA Epstein, Alan L. RA Kaplan, Henry Seymour RT "Feeder layer and nutritional requirements for the establishment and RT cloning of human malignant lymphoma cell lines."; RL Cancer Res. 39:1748-1759(1979). // RX PubMed=23292937; DOI=10.1073/pnas.1205299110; PMCID=PMC3557051; RA Zhang, Jenny RA Grubor, Vladimir RA Love, Cassandra L. RA Banerjee, Anjishnu RA Richards, Kristy L. RA Mieczkowski, Piotr Andrzej RA Dunphy, Cherie RA Choi, William Wai-Lap RA Au, Wing Yan RA Srivastava, Gopesh RA Lugar, Patricia Lynne RA Rizzieri, David A. RA Lagoo, Anand S. RA Bernal-Mizrachi, Leon RA Mann, Karen P. RA Flowers, Christopher Robert RA Naresh, Kikkeri N. RA Evens, Andrew M. RA Gordon, Leo I. RA Czader, Magdalena B. RA Gill, Javed Iqbal RA Hsi, Eric Darryl RA Liu, Qing-Quan RA Fan, Alice RA Walsh, Katherine RA Jima, Dereje RA Smith, Lisa L. RA Johnson, Amy J. RA Byrd, John C. RA Luftig, Micah Alan RA Ni, Ting RA Zhu, Jun RA Chadburn, Amy RA Levy, Shawn RA Dunson, David Brian RA Dave, Sandeep S. RT "Genetic heterogeneity of diffuse large B-cell lymphoma."; RL Proc. Natl. Acad. Sci. U.S.A. 110:1398-1403(2013). // RX PubMed=19358282; DOI=10.1002/ijc.24351; RA Inagaki, Atsushi RA Ishida, Takashi RA Yano, Hiroki RA Ishii, Toshihiko RA Kusumoto, Shigeru RA Ito, Asahi RA Ri, Masaki RA Mori, Fumiko RA Ding, Jian-Min RA Komatsu, Hirokazu RA Iida, Shinsuke RA Ueda, Ryuzo RT "Expression of the ULBP ligands for NKG2D by B-NHL cells plays an RT important role in determining their susceptibility to RT rituximab-induced ADCC."; RL Int. J. Cancer 125:212-221(2009). // RX PubMed=8547074; DOI=10.1111/j.1365-2141.1995.tb05302.x; RA Siebert, Reiner RA Willers, Christoph P. RA Schramm, Alexander RA Fossa, Alexander RA Dresen, Irina M. Gana RA Uppenkamp, Michael J. RA Nowrousian, Mohammad Resa RA Seeber, Siegfried RA Opalka, Bertram RT "Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and RT lymphoblastic leukaemia cell lines."; RL Br. J. Haematol. 91:350-354(1995). // RX PubMed=3881165; DOI=10.1016/0165-4608(85)90186-4; RA Kaiser-McCaw Hecht, Barbara RA Epstein, Alan L. RA Berger, Carol S. RA Kaplan, Henry Seymour RA Hecht, Frederick RT "Histiocytic lymphoma cell lines: immunologic and cytogenetic RT studies."; RL Cancer Genet. Cytogenet. 14:205-218(1985). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=83902; DOI=10.1002/1097-0142(197901)43:1<1::AID-CNCR2820430102>3.0.CO;2-M; RA Kaplan, Henry Seymour RA Goodenow, Robert S. RA Gartner, Suzanne RA Bieber, Marcia M. RT "Biology and virology of the human malignant lymphomas: 1st Milford D. RT Schulz lecture."; RL Cancer 43:1-24(1979). // RX PubMed=214220; DOI=10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; RA Epstein, Alan L. RA Levy, Ronald RA Kim, Hun RA Henle, Werner RA Henle, Gertrude Szpingier RA Kaplan, Henry Seymour RT "Biology of the human malignant lymphomas. IV. Functional RT characterization of ten diffuse histiocytic lymphoma cell lines."; RL Cancer 42:2379-2391(1978). // RX PubMed=19278952; DOI=10.1182/blood-2009-01-202028; PMCID=PMC3401058; RA Li, Cheng RA Kim, Sang-Woo RA Rai, Deepak RA Bolla, Aswani R. RA Adhvaryu, Siddharth RA Kinney, Marsha C. RA Robetorye, Ryan S. RA Aguiar, Ricardo C.T. RT "Copy number abnormalities, MYC activity, and the genetic fingerprint RT of normal B cells mechanistically define the microRNA profile of RT diffuse large B-cell lymphoma."; RL Blood 113:6681-6690(2009). // RX PubMed=9787181; DOI=10.1182/blood.V92.9.3410; RA Sakai, Akira RA Thieblemont, Catherine RA Wellmann, Axel RA Jaffe, Elaine Sarkin RA Raffeld, Mark RT "PTEN gene alterations in lymphoid neoplasms."; RL Blood 92:3410-3415(1998). // RX PubMed=20628145; DOI=10.1182/blood-2010-05-282780; PMCID=PMC2995356; RA Green, Michael Richard RA Monti, Stefano RA Rodig, Scott J. RA Juszczynski, Przemyslaw RA Currie, Treeve RA O'Donnell, Evan RA Chapuy, Bjoern RA Takeyama, Kunihiko RA Neuberg, Donna RA Golub, Todd Robert RA Kutok, Jeffery L. RA Shipp, Margaret Ann RT "Integrative analysis reveals selective 9p24.1 amplification, RT increased PD-1 ligand expression, and further induction via JAK2 in RT nodular sclerosing Hodgkin lymphoma and primary mediastinal large RT B-cell lymphoma."; RL Blood 116:3268-3277(2010). //